Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.48% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Selective Insurance
SIGI
$5.59B
| $19.1M | 0.01% |
293,594
+96,400
| +49% | +$6.67M |
|
1027
EPR Properties
EPR
$4.7B
| $19.1M | 0.01% |
270,300
-42,000
| -13% | -$3.1M |
|
|
MFA
1028
MFA Financial
MFA
$925M
| $19.1M | 0.01% |
623,914
-75,935
| -11% | -$2.32M |
|
1029
The Mosaic Company
MOS
$6.92B
| $19M | 0.01% |
+879,400
| New | +$17.4M |
|
|
FITB
1030
Fifth Third Bancorp
FITB
$52.6B
| $18.9M | 0.01% |
616,139
+185,200
| +43% | +$5.43M |
|
|
VTLE
1031
DELISTED
Vital Energy
VTLE
| $18.9M | 0.01% |
329,608
+102,983
| +45% | +$4.99M |
|
|
SYKE
1032
DELISTED
SYKES Enterprises Inc
SYKE
| $18.9M | 0.01% |
510,700
-54,500
| -10% | -$1.84M |
|
1033
Nasdaq
NDAQ
$53.5B
| $18.9M | 0.01% |
528,900
+385,500
| +269% | +$13.1M |
|
1034
East-West Bancorp
EWBC
$18.5B
| $18.9M | 0.01% |
387,633
-177,600
| -31% | -$8M |
|
|
LSXMA
1035
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $18.9M | 0.01% |
539,813
+210,388
| +64% | +$6.95M |
|
|
XYZ
1036
Block Inc
XYZ
$49.9B
| $18.8M | 0.01% |
+300,900
| New | +$19.2M |
|
|
SCTL
1037
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $18.7M | 0.01% |
1,018,862
+67,767
| +7% | +$974K |
|
|
GAP
1038
The Gap Inc
GAP
$7.29B
| $18.6M | 0.01% |
1,054,300
+875,100
| +488% | +$14.9M |
|
|
CLCT
1039
DELISTED
Collectors Universe
CLCT
| $18.6M | 0.01% |
808,238
+72,300
| +10% | +$1.94M |
|
1040
Rayonier Advanced Materials
RYAM
$561M
| $18.6M | 0.01% |
4,848,316
+429,759
| +10% | +$1.75M |
|
|
EXPR
1041
DELISTED
Express, Inc.
EXPR
| $18.6M | 0.01% |
190,695
+48,655
| +34% | +$3.82M |
|
1042
TTEC Holdings
TTEC
$77.4M
| $18.5M | 0.01% |
467,422
+62,722
| +15% | +$2.75M |
|
1043
Erie Indemnity
ERIE
$13.5B
| $18.5M | 0.01% |
+111,471
| New | +$19.7M |
|
|
CONE
1044
DELISTED
CyrusOne Inc Common Stock
CONE
| $18.5M | 0.01% |
+282,786
| New | +$19.4M |
|
1045
Amdocs
DOX
$6.08B
| $18.5M | 0.01% |
256,300
+235,100
| +1,109% | +$16M |
|
1046
Ardelyx
ARDX
$1.01B
| $18.5M | 0.01% |
2,463,234
+31,100
| +1% | +$189K |
|
1047
Nathan's Famous
NATH
$397M
| $18.5M | 0.01% |
260,820
+4,320
| +2% | +$318K |
|
|
ARD
1048
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $18.4M | 0.01% |
942,193
+147,103
| +19% | +$2.71M |
|
|
OMN
1049
DELISTED
OMNOVA Solutions Inc.
OMN
| $18.4M | 0.01% |
1,824,121
+88,900
| +5% | +$898K |
|
1050
First Bancorp
FBNC
$2.72B
| $18.4M | 0.01% |
461,870
-155,444
| -25% | -$5.95M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.